Literature DB >> 28090786

Inorganic nitrite modulates miRNA signatures in acute myocardial in vivo ischemia/reperfusion.

Ulrike B Hendgen-Cotta1, Daniel Messiha1, Sonja Esfeld1, René Deenen2, Tienush Rassaf1, Matthias Totzeck1.   

Abstract

Acute myocardial infarction is the leading cause of mortality in the industrialized world. While it is essential to attempt an early reperfusion of ischemic myocardial territories, reperfusion itself adds damage to the heart, the ischemia-reperfusion (I/R) injury. Particularly the injury resulting from the very first minutes of reperfusion remains incompletely understood. MicroRNAs (miRNAs) are dynamic regulators in I/R injury. Nitric oxide (•NO) signaling, in turn, interacts with miRNA signaling. Our previous investigations showed that •NO signaling in I/R could be modulated by nitrite. We therefore sought to investigate the role of miRNAs in nitrite cardioprotection with focus on the first few minutes of reperfusion. The study was conducted in mice in vivo with 30 min of ischemia and 5 min of reperfusion. Mice received a single-dose of nitrite or saline intracardially 5 min prior to reperfusion. We identified nine miRNAs to be up-regulated after 5 min of reperfusion. The up-regulation of almost half of those miRNAs (miR-125a-5p, miR-146b, miR-339-3p, miR-433) was inhibited by nitrite treatment, perpetuating baseline values. In silico analysis revealed the Irak-M gene to be a target of miR-146b and miR-339-3p. Correspondingly, a rise in Irak-M transcript and protein levels occurred by nitrite treatment within the early phase of reperfusion. The results demonstrate that already a very short phase of reperfusion is sufficient for significant dysregulation in cardiac miRNAs expression and that nitrite preserves baseline values of miRNAs in the scale of only a few minutes. These findings hint at a potential novel cardioprotective mechanism of nitrite signaling.

Entities:  

Keywords:  Ischemia/reperfusion injury; mRNA; microRNA; nitric oxide; nitrite

Mesh:

Substances:

Year:  2017        PMID: 28090786     DOI: 10.1080/10715762.2017.1282158

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  10 in total

1.  Circular RNA-DENND4C in H9c2 cells relieves OGD/R-induced injury by down regulation of microRNA-320.

Authors:  Jun Zhang; Tao Zhang; Wenlong Zhang; Chengwei Zou; Qian Zhang; Xiaochun Ma; Yanhui Zhu
Journal:  Cell Cycle       Date:  2020-10-22       Impact factor: 4.534

2.  miR-125a, miR-139 and miR-324 contribute to Urocortin protection against myocardial ischemia-reperfusion injury.

Authors:  Ignacio Díaz; Eva Calderón-Sánchez; Raquel Del Toro; Javier Ávila-Médina; Eva Sánchez de Rojas-de Pedro; Alejandro Domínguez-Rodríguez; Juan Antonio Rosado; Abdelkrim Hmadcha; Antonio Ordóñez; Tarik Smani
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

3.  MicroRNA-30e protects the heart against ischemia and reperfusion injury through autophagy and the Notch1/Hes1/Akt signaling pathway.

Authors:  Jianjie Zheng; Jing Li; Bo Kou; Qiuyue Yi; Tao Shi
Journal:  Int J Mol Med       Date:  2018-03-07       Impact factor: 4.101

4.  MicroRNAs and histone deacetylase inhibition-mediated protection against inflammatory β-cell damage.

Authors:  Anna Lindeløv Vestergaard; Claus Heiner Bang-Berthelsen; Tina Fløyel; Jonathan Lucien Stahl; Lisa Christen; Farzaneh Taheri Sotudeh; Peter de Hemmer Horskjær; Klaus Stensgaard Frederiksen; Frida Greek Kofod; Christine Bruun; Lukas Adrian Berchtold; Joachim Størling; Romano Regazzi; Simranjeet Kaur; Flemming Pociot; Thomas Mandrup-Poulsen
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

Review 5.  Therapeutic Value of miRNAs in Coronary Artery Disease.

Authors:  Md Sayed Ali Sheikh; A Alduraywish; A Almaeen; Mubarak Alruwali; Raed Alruwaili; Basil Mohammed Alomair; Umme Salma; Gomaa Mostafa Hedeab; Najeebullah Bugti; Ibrahim A M Abdulhabeeb
Journal:  Oxid Med Cell Longev       Date:  2021-04-12       Impact factor: 6.543

Review 6.  MiR-125 Family in Cardiovascular and Cerebrovascular Diseases.

Authors:  Yang Wang; Jing Tan; Lu Wang; Gaiqin Pei; Hongxin Cheng; Qing Zhang; Shiqi Wang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Front Cell Dev Biol       Date:  2021-12-02

7.  Long non-coding RNA MIR4435-2HG/microRNA-125a-5p axis is involved in myocardial ischemic injuries.

Authors:  Xiuling Wang; Lina Ren; Shuai Chen; Yanli Tao; Dandan Zhao; Chunwei Wu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 8.  The Emerging Role of Noncoding RNA Regulation of the Ferroptosis in Cardiovascular Diseases.

Authors:  Jing Zhang; Xinran Liu; Xiaozhong Li; Yuxi Cai; Yiwen Zhou; Qiong Wang; Zhou Xu; Panpan Xia; Pingping Yang; Lei Jun; Peng Yu; Ao Shi
Journal:  Oxid Med Cell Longev       Date:  2022-09-21       Impact factor: 7.310

9.  Sufentanil preconditioning protects against myocardial ischemia/reperfusion injury via miR-125a/DRAM2 axis.

Authors:  Qiaoling Wu; You Shang; Yanli Bai; Yuanyuan Wu; Hao Wang; Tu Shen
Journal:  Cell Cycle       Date:  2021-01-21       Impact factor: 4.534

10.  RiPerC Attenuates Cerebral Ischemia Injury through Regulation of miR-98/PIK3IP1/PI3K/AKT Signaling Pathway.

Authors:  Dengwen Zhang; Li Mei; Ruichun Long; Can Cui; Yi Sun; Sheng Wang; Zhengyuan Xia
Journal:  Oxid Med Cell Longev       Date:  2020-10-05       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.